MUMBAI, India, July 5 -- Intellectual Property India has published a patent application (202517057718 A) filed by Arnatar Therapeutics, Inc, San Diego, on June 16, for 'arnatar compounds and methods for enhanced cellular uptake.'
Inventor(s) include Steiner, Derek; Wang, Yanfeng; and Liang, Xuehai.
The application for the patent was published on July 4, under issue no. 27/2025.
According to the abstract released by the Intellectual Property India: "This invention generally relates to the field of compounds and methods for enhanced cellular uptake. In particular. the invention relates to N-acetylgalactosamine compounds and their conjugates. Also provided are methods tor the preparation of these molecules and possible uses thereof, in particular in medicine."
The patent application was internationally filed on Dec. 18, 2023, under International application No.PCT/US2023/084692.
Disclaimer: Curated by HT Syndication.
